SCHEMBL8992059

SCHEMBL8992059

CO[C@H]1O[C@@H](CCO)[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@H]1OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SSTR1 P30872 1/20 0.58
▸ SSTR2 P30874 1/20 0.58
▸ SSTR4 P31391 1/20 0.58
▸ SSTR3 P32745 1/20 0.58
▸ SSTR5 P35346 1/20 0.58
▸ BCHE P06276 1/20 0.55
▸ PTPN1 P18031 6/20 0.48
▸ PTPN2 P17706 4/20 0.48
▸ LGALS8 O00214 1/20 0.46
▸ CDC25B P30305 4/20 0.42
▸ CDC25A P30304 1/20 0.42
▸ SLC6A2 P23975 1/20 0.41
▸ PDPK1 O15530 1/20 0.41
▸ MTOR P42345 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3629879 1.00 SSTR1 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8577464 1.00 SSTR1 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8992056 1.00 SSTR1 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
Alcohol SCHEMBL9191479 0.97 SSTR1 (0.56) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8991996 0.95 SSTR1 (0.59) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8991993 0.95 SSTR1 (0.59) SSTR1SSTR2SSTR4SSTR3SSTR5
Alcohol SCHEMBL8992051 0.93 SSTR1 (0.57) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL25084148 0.90 PTPN1 (0.47) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL3467442 0.89 SSTR1 (0.60) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL21440458 0.89 SSTR1 (0.60) SSTR1SSTR2SSTR4SSTR3SSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5504078-A α-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1996-04-02 — — US disclosed
EP-0532668-B1 NOVEL ALPHA-GLUCOSIDASE INHIBITORS MERRELL DOW PHARMA (US) 1995-11-15 — — EP disclosed
EP-0345104-B1 Novel Alpha-glucosidase inhibitors MERRELL DOW PHARMA (US) 1995-11-02 — — EP disclosed
EP-0422975-B1 Alpha-glucosidase inhibitors MERRELL DOW PHARMA (US) 1994-07-27 — — EP disclosed
US-5157116-A Antidiabetic agents MERRELL DOW PHARMACEUTICALS INC. (US) 1992-10-20 — — US disclosed
US-5097023-A α-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1992-03-17 — — US disclosed
EP-0422975-A1 Alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1991-04-17 — — EP disclosed
EP-0422307-A1 Novel alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1991-04-17 — — EP disclosed
EP-0389723-A1 Novel alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1990-10-03 — — EP disclosed
EP-0390674-A1 Novel alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1990-10-03 — — EP disclosed
EP-0345104-A2 Novel Alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1989-12-06 — — EP disclosed
EP-0344383-A1 Novel alpha-Glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1989-12-06 — — EP disclosed
Send feedback